DUFKOVÁ, Kristýna, Matěj BEZDÍČEK, Markéta NYKRÝNOVÁ, Iva KOCMANOVÁ, Petra KUBÁČKOVÁ, Jana HANSLIKOVA, Karolina FEJKOVA, Jiří MAYER a Martina LENGEROVÁ. Rapid Identification of Pseudomonas aeruginosa International High-Risk Clones Based on High-Resolution Melting Analysis. Microbiology Spectrum. WASHINGTON: AMER SOC MICROBIOLOGY, 2023, roč. 11, č. 1, s. 1-9. ISSN 2165-0497. Dostupné z: https://dx.doi.org/10.1128/spectrum.03571-22.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Rapid Identification of Pseudomonas aeruginosa International High-Risk Clones Based on High-Resolution Melting Analysis
Autoři DUFKOVÁ, Kristýna (203 Česká republika, domácí), Matěj BEZDÍČEK (203 Česká republika), Markéta NYKRÝNOVÁ (203 Česká republika), Iva KOCMANOVÁ (203 Česká republika), Petra KUBÁČKOVÁ (203 Česká republika), Jana HANSLIKOVA (203 Česká republika), Karolina FEJKOVA (203 Česká republika), Jiří MAYER (203 Česká republika, domácí) a Martina LENGEROVÁ (203 Česká republika, garant, domácí).
Vydání Microbiology Spectrum, WASHINGTON, AMER SOC MICROBIOLOGY, 2023, 2165-0497.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10606 Microbiology
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 3.700 v roce 2022
Kód RIV RIV/00216224:14110/23:00131013
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1128/spectrum.03571-22
UT WoS 000911842300001
Klíčová slova anglicky Pseudomonas aeruginosa; high-resolution melting; mini-MLST; molecular epidemiology; strain typing
Štítky 14110212, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 30. 1. 2024 12:48.
Anotace
The Pseudomonas aeruginosa population has a nonclonal epidemic structure. It is generally composed of a limited number of widespread clones selected from a background of many rare and unrelated genotypes recombining at high frequency. Due to the increasing prevalence of nosocomial infections caused by multidrug-resistant/extensively drug-resistant (MDR/XDR) strains, it is advisable to implement infection control measures. Pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) are considered the gold standard methods in bacterial typing, despite being limited by cost, staff, and instrumental demands. Here, we present a novel mini-MLST scheme for P. aeruginosa rapid genotyping based on high-resolution melting analysis. Using the proposed mini-MLST scheme, 3,955 existing sequence types (STs) were converted into 701 melting types (MelTs), resulting in a discriminatory power of D = 0.993 (95% confidence interval [CI], 0.992 to 0.994). Whole-genome sequencing of 18 clinical isolates was performed to support the newly designed mini-MLST scheme. The clonal analysis of STs belonging to MelTs associated with international high-risk clones (HRCs) performed by goeBURST software revealed that a high proportion of the included STs are highly related to HRCs and have also been witnessed as responsible for serious infections. Therefore, mini-MLST provides a clear warning for the potential spread of P. aeruginosa clones recognized as MDR/XDR strains with possible serious outcomes.IMPORTANCE In this study, we designed a novel mini-MLST typing scheme for Pseudomonas aeruginosa. Its great discriminatory power, together with ease of performance and short processing time, makes this approach attractive for prospective typing of large isolate sets. Integrating the novel P. aeruginosa molecular typing scheme enables the development and spread of MDR/XDR high-risk clones to be investigated. In this study, we designed a novel mini-MLST typing scheme for Pseudomonas aeruginosa. Its great discriminatory power, together with ease of performance and short processing time, makes this approach attractive for prospective typing of large isolate sets. Integrating the novel P. aeruginosa molecular typing scheme enables the development and spread of MDR/XDR high-risk clones to be investigated.
Návaznosti
MUNI/A/1224/2022, interní kód MUNázev: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit X
Investor: Masarykova univerzita, Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit X
VytisknoutZobrazeno: 6. 5. 2024 01:50